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Purpose: The R124H mutation of the keratoepithelin gene (TGFBI) causes Avellino corneal dystrophy whereas the N544S
mutation of this same gene gives rise to lattice corneal dystrophy. We now report two cases with both R124H and N544S
mutations of TGFBI.
Methods: Genomic DNA and cDNA were isolated from the proband and family members and were subjected to
polymerase chain reaction–mediated amplification of exons 1–17 of TGFBI. The amplification products were directly
sequenced. Allele-specific cloning and sequencing were applied to evaluate the compound heterozygous mutation.
Results: Molecular genetic analysis revealed that the proband and one sister harbored both a heterozygous CGC→CAC
(Arg→His) mutation at codon 124 and a heterozygous AAT→AGT (Asn→Ser) mutation at codon 544 of TGFBI. Slit-
lamp examination revealed multiple granular regions of opacity and lattice lines in the corneal stroma of the proband and
her sister with the double mutation. Allele-specific cloning and sequencing revealed that the R124H and N544S mutations
are on different chromosomes.
Conclusions: As far as we are aware, this is the first report of a patient with a double mutation (R124H, N544S) of TGFBI
causing an autosomal dominant form of corneal dystrophy. The clinical manifestations of the two cases with both R124H
and N544S mutations appeared to be a summation of Avellino and lattice corneal dystrophies.
Mutations  of  the  keratoepithelin  gene  (TGFBI)  are
responsible for most corneal dystrophies. TGFBI was first
identified  as  a  transforming  growth  factor-β1  (TGF-β1)-
inducible gene in a human lung adenocarcinoma cell line [1].
The point mutations R124C, R124H, R555W, and R555Q of
TGFBI were initially found to give rise to lattice corneal
dystrophy  (LCD),  Avellino  corneal  dystrophy  (ACD),
Groenouw  type  I  corneal  dystrophy,  and  Reis-Bücklers
corneal  dystrophy,  respectively  [2].  Many  additional
mutations  of  TGFBI  were  subsequently  found  to  be
responsible for autosomal dominant corneal dystrophies [3,
4]. ACD is characterized by the presence of granular and linear
opacities in the corneal stroma. The deposits in the corneal
stroma of patients with ACD are of a hyaline and amyloid
nature. The only identified mutation associated with ACD is
R124H of TGFBI [2]. LCD is an inherited form of amyloidosis
that is characterized by the development of lattice lines and
opacities in the cornea. Several distinct mutations of TGFBI
including  R124C  [2],  L518P  [5],  P501T  [6],  L527R  [7],
N544S [8], A546T [9], and N622K (T1913G or T1913A) [3]
have been associated with LCD. LCD is classified clinically
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into several subtypes [3,4], but standardized definitions of
each subtype have not been achieved to date. The subtype of
LCD caused by the N544S mutation of TGFBI is characterized
by tiny nodular deposits with thin lattice lines in the middle
portion of the corneal stroma [10].
Several  case  reports  have  suggested  that  corneal
dystrophies caused by homozygous point mutations of TGFBI
are characterized by an earlier onset, more severe symptoms,
and  a  higher  frequency  of  recurrence  after  keratoplasty
compared  with  those  attributable  to  the  corresponding
heterozygous mutations [11-15]. A few case reports have also
described individuals with corneal dystrophy who harbor two
distinct  mutations  in  TGFBI,  the  membrane  component,
chromosome 1, surface maker 1 (M1S1), or both [16-21]. It
has remained unclear, however, how the phenotype of patients
with such a double mutation differs from that of those with
the corresponding single mutations. We now describe the first
cases of corneal dystrophy associated with both R124H and
N544S mutations of TGFBI.
METHODS
This study was approved by the ethical review committee for
gene analysis research of Yamaguchi University School of
Medicine  and  Yamaguchi  University  Hospital.  After
obtaining informed written consent, we extracted genomic
DNA from white blood cells of peripheral blood collected
from patients in the presence of an anticoagulant. Total RNA
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974was also extracted from the white blood cells with the use of
a QIAmp RNA Blood mini kit (Qiagen, Valencia, CA) and
was then subjected to reverse transcription with the use of
TaqMan  Reverse  Transcription  Reagents  (Applied
Biosystems, Foster City, CA). The resulting cDNA as well as
genomic DNA were subjected to polymerase chain reaction
(PCR) with primers that amplify exons 1, 4, 11, 12, 13, 14, 2–
9,  or  9–17  of  TGFBI  (Table  1).  Each  PCR  reaction  was
performed in a total volume of 10 μl containing template DNA
(80  ng/μl),  10  pmol  of  each  primer,  200  μM  of  each
deoxynucleoside triphosphate, 20 mM MgCl2, 20 mM Tris-
HCl (pH 8.0), 100 mM KCl, and 1 U of Taq polymerase (Ex
Figure  1.  Pedigree  of  the  proband.  Black  symbols  indicate
individuals with a diagnosis of corneal dystrophy by genetic analysis.
Gray symbols indicate individuals suspected of having been affected
by corneal dystrophy but not subjected to genetic analysis. The arrow
indicates the proband.
Taq;  Takara,  Tokyo,  Japan).  The  reaction  mixture  was
overlaid with 10 μl of mineral oil, and amplification was
performed with a Gene Amp PCR System PC808 (ASTEC,
Tokyo, Japan) with an initial denaturation at 95 °C for 2 min
followed by 30 cycles of denaturation at 94 °C for 30 s,
annealing at 58 °C, 60 °C, or 62 °C (Table 1) for 20 s, and
extension at 72 °C for 30 s. The PCR products were separated
by  electrophoresis  on  a  2%  agarose  gel  and  stained  with
ethidium bromide. For sequencing, 2.5 µl of the PCR products
were  incubated  with  1  μl  of  ExoSAP-IT  (Amersham
Bioscience, Tokyo, Japan) first for 20 min at 37 °C and then
for another 20 min at 80 °C. Sequencing reactions were then
performed  with  the  use  of  a  BigDye  Terminator  Cycle
Sequencing FS Ready Reaction Kit (Applied Biosystems).
After purification with ethanol, the reaction products were
applied to an ABI 3100-Avant Genetic Analyzer (Applied
Biosystems).
An allele-specific cloning and sequencing approach was
applied to characterize the compound heterozygous mutation
of R124H and N544S. In brief, cDNA of the proband was
subjected to PCR with KOD FX DNA polymerase (Toyobo,
Tokyo, Japan) and with the primers, 5′-TGT CCA GCA GCC
CTA CCA CTC-3′ (forward) and 5′-AGG ATA TCC CCT
CTT TCC TGA GGT C-3′ (reverse; containing an EcoRV
restriction site at its 5′ end), to obtain products that included
both  mutation  sites.  The  PCR  products  were  purified  by
electrophoresis and digested with EcoRV and BamHI (site in
exon 4), and the released fragments were ligated into the
multiple cloning site of a sequencing vector (pcDNA3.1[+];
Promega,  Madison,  WI).  The  resulting  plasmids  were
expanded  in  competent  Escherichia  coli  JM109  cells
(Invitrogen,  Carlsbad,  CA),  and  the  inserts  were  then
sequenced as described above.
TABLE 1. PCR PRIMERS USED FOR SEQUENCING EXONS OF TGFBI.
Exon Primer Primer sequence Annealing
temperature (°C)
Product size
(bp)
2–9 cDNA-F1 5'-CGCCAAGTCGCCCTACCAG-3' 60 1205
cDNA-R1 5'-TTGGAGGGGTTCCATCTTTG-3'
9–17 cDNA-F2 5'-CTCATCCCAGACTCAGCCAA-3' 60 1075
cDNA-R2 5'-CACATCTCATTATGGTGCGGC-3'
1 DNA-1F 5'-CCGCTCGCAGCTTACTTAAC-3' 60 362
DNA-1R 5'-AGCGCTCCAATGCTGCAAGGT-3'
4 DNA-4F 5'-CGTCCTCTCCACCTGTAGAT-3' 62 350
DNA-4R 5'-GACTCCCATTCATCATGCCC-3'
11 DNA-11F 5'-CAGCCTTAATAACCCATCCCA-3' 58 375
DNA-11R 5'-AATCCCCAAGGTAGAAGAAAG-3'
12 DNA-12F 5'-AGGAAAATACCTCTCAGCGTGG-3' 60 293
DNA-12R 5'-ATGTGCCAACTGTTTGCTGC-3'
13 DNA-13F 5'-GGGAGTTCTTCATTTCAGGG-3' 58 365
DNA-13R 5'-ATTACACTCAGAGATTCGGG-3'
14 DNA-14F 5'-GCCTGGGCGACAAGATTGA-3' 58 419
DNA-14R 5'-CCAACAGCTCCCAATTCAC-3'
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The proband, a 67-year-old Japanese woman (II-1), visited
our corneal clinic in January 2000 with a main complaint of
gradual impairment of vision (Figure 1). We diagnosed her
condition  as  ACD  on  the  basis  of  slit-lamp  examination.
Given that her visual acuity had decreased to 0.7 in the right
eye and 0.4 in the left eye, we performed phototherapeutic
keratectomy on her left eye in March 2000 and on her right
eye in May 2000. The parents of II-1 were not related to each
other. Her father (I-1) is no longer alive, and she has two
Figure 2. Slit-lamp photographs of the proband and her two sisters. Slit-lamp photographs of the right eye of II-1 (A–C), the left eye of II-2
(D–F), and the left eye of II-3 (G–I) are shown. Granular deposits (gray arrowheads) and star-shaped deposits (black arrowheads) were
observed in all three patients (C,F,I) whereas thin lattice lines (black arrows) were observed only in II-1 (C) and II-3 (I). Nodular deposits
were apparent mostly in the superficial-to-middle portion of the corneal stroma in all three patients (B,E,H).
Figure 3. Lattice lines in patient's cornea. The lattice lines referred to in Figure 2 are better visualized in the higher magnifications of Figure
2C, Figure 2F, and Figure 2I (Figure 3A-C, respectively). The lattice lines are easily seen in A and C (black arrows), but not in B.
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976brothers and two sisters. Her father’s brother (I-2) and her
sisters (II-2, II-3) were also diagnosed at our clinic with ACD
by slit-lamp examination. Her reporting suggested that her
father  (I-1)  had  corneal  dystrophy.  We  also  performed
phototherapeutic keratectomy on the left eye of II-2 in March
2000 and on the right eye of II-2 in May 2000.
Slit-lamp  examination  subsequently  revealed  multiple
granular regions of opacity in the surface-to-middle portion
of the corneal stroma in both eyes of II-1, II-2, and II-3. Lattice
lines  were  also  observed  in  II-1  (Figure  2A–C)  and  II-3
(Figure 2G–I) but not in II-2 (Figure 2D–F). These lattice lines
can be seen better in the higher magnifications of Figure 2C,
Figure 2F and Figure 2I (Figure 3A-C, respectively). Both II-1
and  II-3  were  found  to  harbor  both  a  heterozygous
CGC→CAC  (Arg→His)  mutation  at  codon  124  and  a
heterozygous AAT→AGT (Asn→Ser) mutation at codon 544
of  TGFBI  whereas  II-2  harbored  only  the  heterozygous
CGC→CAC (Arg→His) mutation at codon 124 (Figure 4).
The mutations were identified at both the genomic and cDNA
levels.
To investigate whether the two TGFBI mutations are on
the  same  or  different  chromosomes  of  the  proband,  we
adopted an allele-specific cloning and sequencing approach.
PCR products containing both mutation sites were subcloned
and sequenced. Of three independent clones analyzed, one
contained  only  the  R124H  mutation  and  the  other  two
contained only the N544S mutation, indicating that the two
mutations are on different chromosomes.
DISCUSSION
As far as we are aware, this is the first report of a patient with
a double mutation of TGFBI causing an autosomal dominant
form of corneal dystrophy. The clinical manifestations of the
two cases with both R124H and N544S mutations appeared
to be a summation of those of Avellino and lattice corneal
dystrophies. We observed lattice lines in the corneas of II-1
and II-3, both of whom have the N544S mutation of TGFBI,
but not in II-2, who harbors only the R124H mutation.
We were not able to perform genetic analysis on I-1 and
I-2 because they were no longer alive at the time of this
analysis.  However,  allele-specific  cloning  and  sequencing
revealed that the R124H and N544S mutations are on different
chromosomes, consistent with our clinical findings. Slit-lamp
examination of I-2 did not reveal the presence of lattice lines,
suggesting that the R124H mutation was transmitted to the
proband  and  her  two  sisters  from  I-1.  Although  slit-lamp
examination was not performed on the mother of the three
sisters because of her being confined to bed, it is likely that
she harbors the N544S mutation of TGFBI. Given that the
clinical manifestation of the N544S mutation has a late onset
and that the mutation does not have a pronounced effect on
visual  acuity,  the  mother  may  not  experience  a  visual
disturbance.
Several cases of double mutations associated with corneal
dystrophies other than macular corneal dystrophy have been
described previously (Table 2). However, no case of a double
mutation of TGFBI causing an autosomal dominant form of
corneal dystrophy has previously been reported. The presence
of  a  homozygous  Q118X  mutation  of  M1S1  and  a
heterozygous  P501T  mutation  of  TGFBI  in  the  same
individual was described [16]. The Q118X mutation of M1S1
causes gelatinous drop-like corneal dystrophy (GDLD) with
an  autosomal  recessive  mode  of  inheritance.  The  P501T
mutation of TGFBI causes LCD type IIIA [6]. The clinical
manifestation in this patient resembled that of GDLD but not
that of LCD type IIIA. A patient with a clinical diagnosis of
GDLD and heterozygous Q118X and Y184C mutations of
M1S1 has also been described [17]. No other case of the
Y184C mutation in M1S1 has been presented, so it is not clear
whether this mutation in the homozygous state can cause
GDLD. A patient with a clinical diagnosis of GDLD was
found  to  be  heterozygous  for  both  Q118X  and  L186P
Figure 4. Genetic analysis of TGFBI in the proband and her two sisters. Direct sequencing of genomic amplification products corresponding
to exon 4 (upper panels) or exon 12 (lower panels) of TGFBI was performed for II-1, II-2, and II-3. A heterozygous CGC→CAC mutation
was detected at codon 124 in II-1, II-2, and II-3. A heterozygous AAT→AGT mutation was detected at codon 544 in II-1 and II-3.
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977mutations of M1S1 [18]. Patients with a clinical diagnosis of
atypical LCD were found to be heterozygous for both A546D
and P551Q mutations of TGFBI [19,20]. The A546D mutation
of TGFBI causes polymorphic corneal amyloidosis [22] or
atypical  LCD  [23]  with  an  autosomal  dominant  mode  of
inheritance. There have been no other reports of the P551Q
mutation of TGFBI, so it is not clear whether a heterozygous
P551Q mutation causes corneal dystrophy. Finally, a patient
with a clinical diagnosis of granular corneal dystrophy was
found to be heterozygous for both R124L and ΔT125-ΔE126
mutations of TGFBI [21]. There have been no other reports of
the ΔT125-ΔE126 mutation of TGFBI.
A few studies have addressed the penetrance of inherited
corneal  dystrophy.  LCD  type  IIIA  caused  by  the  P501T
mutation  of  TGFBI  [16]  and  atypical  granular  corneal
dystrophy caused by the D123H mutation of TGFBI [24] are
thought to have a low penetrance. Non-penetrance of ACD
has  also  been  described  [25].  The  penetrance  of  corneal
dystrophies caused by the R124H or N544S mutations of
TGFBI remains unclear.
In all previously reported cases of double mutations, the
clinical phenotype resembled that of one but not both of the
associated corneal dystrophies. In the cases described in the
present  study,  the  phenotype  associated  with  the  double
mutation is the summation of both corneal dystrophies. These
cases  thus  indicate  that  R124H  and  N544S  mutations  of
TGFBI independently determine clinical manifestation.
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